Trial Profile
A Multicenter Phase III Clinical Study to Evaluate the Efficacy and Tolerability of Transdermal Tulobuterol in Indian Adult Patients of clinically stable Bronchial Asthma and COPD.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Jan 2020
Price :
$35
*
At a glance
- Drugs Tulobuterol (Primary) ; Salmeterol
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- Sponsors Sparsha Pharma
- 03 Mar 2011 New trial record